Avono Health review

Four microdose plans, both molecules, injection and tablet, each with its own month-to-month figure on a single page, no prepay footnote and no first-month asterisk anywhere — this is what a low-dose price list should look like, and almost nothing else here comes close. The catch is precise and easy to miss: the promise that the price never rises with the dose is written to cover the standard plans, and is never extended to the microdose line. So the one commitment a microdose buyer most needs in writing is the one they do not get, and no milligram figure is published for any microdose tier either.

Vs median

$4/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Charges less for less

Consult

Included in the price

Dietitian

Not confirmed

Labs

Optional

Pricing

Flat at every dose

Avono Health does not publicly identify the pharmacy that fills its prescriptions. Bloodwork is offered but not required. A clinician review is included in the price.

Avono Health, operated by Avono LLC, is a U.S. telehealth platform selling compounded semaglutide and tirzepatide in injectable and oral form under four flat monthly plans, plus NAD+ and sermorelin programs. Care is fully asynchronous: intake, clinician review, then shipment, with a patient portal of its own. Its medical-oversight page names its telehealth infrastructure partner and its clinical group, and identifies two supervising physicians by name and NPI — both of which verify as active records in the CMS registry. It says medication is prepared by state-licensed U.S. compounding pharmacies but names no pharmacy and states no 503A or 503B designation. There is no membership fee and no consult fee; the clinician visit and shipping are included.

The flat-price guarantee is written for the standard semaglutide and tirzepatide plans only. Avono never says the $179 microdose price holds as the microdose is titrated upward, which is the single thing a microdose buyer most needs in writing

• No milligram figure is published for any of the four microdose plans; the entire dose description is a gentler, lower-dose introduction
• No multi-month microdose bundle is priced, so the microdose buyer cannot reach the discount the standard buyer can
• Never states a 503A or 503B designation and never names a compounding pharmacy, despite building its whole weight-management page around a made-in-the-US argument
• No LegitScript seal or certification is displayed anywhere on the site
• The homepage runs an interactive slider that tells a visitor how much weight they can easily lose — an unqualified outcome projection attached to a prescription drug, with testimonials attributed only as verified clients
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Avono Health is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Microdosing semaglutide
• Oral semaglutide (Rybelsus)
• What a flat price costs at a low dose
• Microdose & reconstitution calculator